Newly diagnosed breast cancer is most commonly classified into one of several molecular or intrinsic subtypes according to the status or level of ER and PR sex hormone receptor expression, growth factor receptor HER2, and proliferation marker Ki-67. This evidence concerns the gene MKI67 and breast cancer.